SPRB
Geode Capital Management’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-276,708
| Closed | -$80.3K | – | 4551 |
|
|
2025
Q1 | $80.3K | Buy |
276,708
+2,923
| +1% | +$848 | ﹤0.01% | 4090 |
|
|
2024
Q4 | $115K | Buy |
273,785
+11,837
| +5% | +$4.97K | ﹤0.01% | 4063 |
|
|
2024
Q3 | $124K | Buy |
261,948
+57,946
| +28% | +$27.5K | ﹤0.01% | 4040 |
|
|
2024
Q2 | $106K | Buy |
204,002
+3,840
| +2% | +$1.99K | ﹤0.01% | 4124 |
|
|
2024
Q1 | $157K | Buy |
200,162
+32,758
| +20% | +$25.8K | ﹤0.01% | 4016 |
|
|
2023
Q4 | $491K | Hold |
167,404
| – | – | ﹤0.01% | 3619 |
|
|
2023
Q3 | $378K | Sell |
167,404
-50,507
| -23% | -$114K | ﹤0.01% | 3710 |
|
|
2023
Q2 | $469K | Buy |
217,911
+157,290
| +259% | +$338K | ﹤0.01% | 3671 |
|
|
2023
Q1 | $134K | Hold |
60,621
| – | – | ﹤0.01% | 4228 |
|
|
2022
Q4 | $66K | Sell |
60,621
-134
| -0.2% | -$146 | ﹤0.01% | 4517 |
|
|
2022
Q3 | $83K | Hold |
60,755
| – | – | ﹤0.01% | 4636 |
|
|
2022
Q2 | $105K | Sell |
60,755
-66,273
| -52% | -$115K | ﹤0.01% | 4574 |
|
|
2022
Q1 | $255K | Sell |
127,028
-15,441
| -11% | -$31K | ﹤0.01% | 4259 |
|
|
2021
Q4 | $635K | Buy |
142,469
+31,052
| +28% | +$138K | ﹤0.01% | 3925 |
|
|
2021
Q3 | $669K | Sell |
111,417
-17,129
| -13% | -$103K | ﹤0.01% | 3890 |
|
|
2021
Q2 | $1.44M | Buy |
128,546
+18,999
| +17% | +$213K | ﹤0.01% | 3422 |
|
|
2021
Q1 | $1.82M | Sell |
109,547
-7,971
| -7% | -$132K | ﹤0.01% | 3293 |
|
|
2020
Q4 | $2.86M | Buy |
+117,518
| New | +$2.86M | ﹤0.01% | 2887 |
|